4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001415889-24-005127
Director sold 500,789 shares at an average $22.64 ($11,339,780)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2024-02-21 | Sale 10b5-1 | −149,337 | $22.44 | $3,351,122 | 6,666,628 | I |
| Rhodes Jason P Director | 2024-02-21 | Sale 10b5-1 | −35,164 | $23.14 | $813,695 | 6,631,464 | I |
| Rhodes Jason P Director | 2024-02-22 | Sale 10b5-1 | −119,360 | $22.66 | $2,704,698 | 6,512,104 | I |
| Rhodes Jason P Director | 2024-02-23 | Sale 10b5-1 | −159,542 | $22.70 | $3,621,603 | 6,352,562 | I |
| Rhodes Jason P Director | 2024-02-23 | Sale 10b5-1 | −23,648 | $22.70 | $536,810 | 1,585,137 | I |
| Rhodes Jason P Director | 2024-02-23 | Sale 10b5-1 | −13,738 | $22.70 | $311,853 | 920,843 | I |
| Open-market sales · 500,789 sh · avg $22.64 · $11,339,780 | |||||||
Loading xslF345X05/form4-02232024_110241.xml…